JP2020510119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020510119A5 JP2020510119A5 JP2019549419A JP2019549419A JP2020510119A5 JP 2020510119 A5 JP2020510119 A5 JP 2020510119A5 JP 2019549419 A JP2019549419 A JP 2019549419A JP 2019549419 A JP2019549419 A JP 2019549419A JP 2020510119 A5 JP2020510119 A5 JP 2020510119A5
- Authority
- JP
- Japan
- Prior art keywords
- synthetic
- heparinoid
- synthetic heparinoid
- group
- ost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001499 Heparinoid Polymers 0.000 claims 22
- 239000002554 heparinoid Substances 0.000 claims 22
- 238000000034 method Methods 0.000 claims 11
- 150000002016 disaccharides Chemical group 0.000 claims 7
- 238000005670 sulfation reaction Methods 0.000 claims 6
- 239000000758 substrate Substances 0.000 claims 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical group [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 230000002194 synthesizing effect Effects 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 2
- 108700023372 Glycosyltransferases Proteins 0.000 claims 2
- 102000051366 Glycosyltransferases Human genes 0.000 claims 2
- 206010062506 Heparin-induced thrombocytopenia Diseases 0.000 claims 2
- 108010018682 PRT064445 Proteins 0.000 claims 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 claims 2
- 230000001858 anti-Xa Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 229940097043 glucuronic acid Drugs 0.000 claims 2
- 230000014508 negative regulation of coagulation Effects 0.000 claims 2
- ZXNYUXIMAXVSFN-IVMDWMLBSA-N 2,2,2-trifluoro-n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound OC[C@H]1OC(O)[C@H](NC(=O)C(F)(F)F)[C@@H](O)[C@@H]1O ZXNYUXIMAXVSFN-IVMDWMLBSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 102100023937 Heparan sulfate glucosamine 3-O-sulfotransferase 1 Human genes 0.000 claims 1
- 101001048058 Homo sapiens Heparan sulfate glucosamine 3-O-sulfotransferase 1 Proteins 0.000 claims 1
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 claims 1
- 108010056664 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims 1
- 241000606856 Pasteurella multocida Species 0.000 claims 1
- 102000001708 Protein Isoforms Human genes 0.000 claims 1
- 108010029485 Protein Isoforms Proteins 0.000 claims 1
- 229950002054 andexanet alfa Drugs 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- 239000004019 antithrombin Substances 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 229960002442 glucosamine Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229940025770 heparinoids Drugs 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 229940051027 pasteurella multocida Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002441 reversible effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023129964A JP7702454B2 (ja) | 2017-03-10 | 2023-08-09 | 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762469643P | 2017-03-10 | 2017-03-10 | |
| US62/469,643 | 2017-03-10 | ||
| PCT/US2018/021986 WO2018165656A1 (en) | 2017-03-10 | 2018-03-12 | Short-acting heparin-based anticoagulant compounds and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023129964A Division JP7702454B2 (ja) | 2017-03-10 | 2023-08-09 | 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510119A JP2020510119A (ja) | 2020-04-02 |
| JP2020510119A5 true JP2020510119A5 (enExample) | 2021-04-08 |
| JP7330893B2 JP7330893B2 (ja) | 2023-08-22 |
Family
ID=63449042
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019549419A Active JP7330893B2 (ja) | 2017-03-10 | 2018-03-12 | 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法 |
| JP2023129964A Active JP7702454B2 (ja) | 2017-03-10 | 2023-08-09 | 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023129964A Active JP7702454B2 (ja) | 2017-03-10 | 2023-08-09 | 短時間作用型ヘパリンベースの抗凝集剤化合物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11903963B2 (enExample) |
| EP (1) | EP3579897A4 (enExample) |
| JP (2) | JP7330893B2 (enExample) |
| CN (2) | CN110446511B (enExample) |
| WO (1) | WO2018165656A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11993627B2 (en) | 2017-07-03 | 2024-05-28 | The University Of North Carolina At Chapel Hill | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides |
| EP3691653B1 (en) | 2017-11-03 | 2025-03-12 | The University Of North Carolina At Chapel Hill | Sulfated oligosaccharides having anti-inflammatory activity |
| EP3810152A4 (en) | 2018-06-20 | 2022-04-27 | The University of North Carolina at Chapel Hill | CELL PROTECTION METHODS AND COMPOSITIONS |
| MX2021008479A (es) | 2019-01-15 | 2021-10-13 | Optimvia Llc | Enzimas dependientes de aril sulfato modificadas por ingenieria genetica. |
| CA3144968A1 (en) | 2019-07-09 | 2021-01-14 | Optimvia Llc | Methods for synthesizing anticoagulant polysaccharides |
| JP2023501568A (ja) * | 2019-11-13 | 2023-01-18 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 肝虚血再灌流障害におけるヘパラン硫酸（ｈｓ）オリゴ糖の効果 |
| US20250154290A1 (en) * | 2022-02-17 | 2025-05-15 | Kyushu University, National University Corporation | Recombinant heparin-like substance and method for producing the same |
| CN115417937B (zh) * | 2022-08-12 | 2023-06-06 | 山东大学 | 一种含双抗凝血酶结合序列的肝素十二糖及其制备方法与应用 |
| CN116120484B (zh) * | 2022-09-01 | 2024-11-08 | 山东大学 | 一种抗凝血肝素寡糖苯联二聚体及其制备方法与应用 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| IT1232939B (it) | 1987-11-06 | 1992-03-10 | Opocrin Spa | Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche |
| US4865870A (en) | 1988-07-07 | 1989-09-12 | Becton, Dickinson And Company | Method for rendering a substrate surface antithrombogenic |
| PT93847A (pt) | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
| US5378829A (en) | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
| WO1993005167A1 (en) | 1991-09-06 | 1993-03-18 | Children's Medical Center Corporation | Cell-type specific heparan sulfate proteoglycans and their uses |
| IT1260137B (it) | 1992-04-17 | 1996-03-28 | Alfa Wassermann Spa | Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato |
| US5527785A (en) | 1993-05-14 | 1996-06-18 | The Regents Of The University Of California | Selectin receptor modulating compositions |
| JP3818676B2 (ja) | 1994-07-22 | 2006-09-06 | 生化学工業株式会社 | ヘパラン硫酸６−ｏ−硫酸基転移酵素 |
| IT1271057B (it) | 1994-11-04 | 1997-05-26 | Inalco Spa | Polisaccaridi aventi un elevato contenuto di acido iduronico |
| JP3672359B2 (ja) | 1995-07-24 | 2005-07-20 | 生化学工業株式会社 | ヘパラン硫酸 ２−ｏ−硫酸基転移酵素 |
| JP3713276B2 (ja) | 1995-09-29 | 2005-11-09 | バイオマリン ファーマシューティカル インコーポレイテッド | 炎症反応の軽減のためのヘパリナーゼの使用 |
| US5935824A (en) | 1996-01-31 | 1999-08-10 | Technologene, Inc. | Protein expression system |
| US6861254B1 (en) | 1997-10-24 | 2005-03-01 | Massachusetts Institute Of Technology | Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor |
| US8088604B2 (en) | 1998-04-02 | 2012-01-03 | The Board Of Regents Of The University Of Oklahoma | Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases |
| US6624141B1 (en) | 1999-03-17 | 2003-09-23 | The Regents Of The University Of Michigan | Protamine fragment compositions and methods of use |
| US6255088B1 (en) | 1999-05-11 | 2001-07-03 | The Scripps Research Institute | Enzymatic sulfation of biomolecules |
| US6977248B1 (en) * | 1999-08-25 | 2005-12-20 | Massachusetts Institute Of Technology | Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |
| US7101859B2 (en) | 2000-01-10 | 2006-09-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases |
| CA2698561C (en) | 2000-07-07 | 2012-07-10 | Seikagaku Corporation | Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| CA2441984A1 (en) | 2001-03-28 | 2002-10-10 | Massachusetts Institute Of Technology | Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations |
| WO2002089742A2 (en) | 2001-05-08 | 2002-11-14 | The Board Of Regents Of The University Of Oklahoma | Heparin/heparosan synthase and methods of making and using same |
| PT1401853E (pt) | 2001-05-25 | 2010-12-07 | Univ Duke | Modulador de oligonucleotídeos |
| WO2003018598A2 (en) | 2001-08-30 | 2003-03-06 | University College Dublin | Monosaccharide derivatives |
| US7531338B2 (en) * | 2002-07-05 | 2009-05-12 | The University Of North Carolina At Chapel Hill | Purified and isolated heparan sulfate 3-O-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same |
| GB0216861D0 (en) | 2002-07-19 | 2002-08-28 | Univ Birmingham | Saccharide libraries |
| WO2004017910A2 (en) | 2002-08-23 | 2004-03-04 | Neose Technologies, Inc. | Total synthesis of heparin |
| WO2005014619A2 (en) | 2003-03-28 | 2005-02-17 | Thomas Jefferson University | Heparin-binding peptides and uses thereof |
| US20040259142A1 (en) | 2003-06-04 | 2004-12-23 | Imperial College Innovations Limited | Products and methods |
| EP1529785B1 (en) | 2003-10-24 | 2011-03-16 | 3M Innovative Properties Company | Aqueous dispersions of polytetrafluoroethylene particles |
| US7655445B2 (en) | 2003-11-12 | 2010-02-02 | Massachusetts Institute Of Technology | Methods for synthesis of sulfated saccharides |
| WO2005118609A2 (en) | 2004-05-26 | 2005-12-15 | California Institute Of Technology | Small molecule stimulators of neuronal growth |
| US20050282775A1 (en) | 2004-06-16 | 2005-12-22 | Paringenix, Inc. | Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome |
| US20060229276A1 (en) | 2004-07-28 | 2006-10-12 | Magnus Hook | Use of glycosoaminoglycans for the prevention and treatment of sepsis |
| US20090197308A1 (en) * | 2005-05-12 | 2009-08-06 | Jian Liu | Enzymatic synthesis of sulfated polysaccharides |
| WO2007023867A1 (ja) | 2005-08-24 | 2007-03-01 | Seikagaku Corporation | 新規コンドロイチン画分製造方法 |
| EP2447285A3 (en) | 2006-05-25 | 2013-01-16 | Momenta Pharmaceuticals, Inc. | Low molecular weight heparin composition and uses thereof |
| WO2009014715A2 (en) | 2007-07-23 | 2009-01-29 | The University Of North Carolina At Chapel Hill | Enzymatic synthesis of sulfated polysaccharides without iduronic acid residues |
| ES2567079T3 (es) | 2007-11-02 | 2016-04-19 | Momenta Pharmaceuticals, Inc. | Composiciones de polisacáridos que no son anticoagulantes |
| US20110009361A1 (en) | 2007-12-21 | 2011-01-13 | Glycan Biosciences Pty Ltd | Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| US8455439B2 (en) | 2008-11-14 | 2013-06-04 | Portola Pharmaceuticals, Inc. | Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents |
| WO2010087207A1 (ja) | 2009-02-02 | 2010-08-05 | 大塚化学株式会社 | 低分子量多硫酸化ヒアルロン酸誘導体及びこれを含有する医薬 |
| SG175133A1 (en) | 2009-04-09 | 2011-12-29 | Univ North Carolina | Methods of treating edema related to ischemia-reperfusion |
| US20110054236A1 (en) | 2009-08-25 | 2011-03-03 | The Regents Of The University Of Michigan | Compositions and methods for targeting tumors |
| WO2011038047A1 (en) | 2009-09-23 | 2011-03-31 | Momenta Pharmaceuticals, Inc. | Methods of treatment with a low molecular weight heparin composition |
| NZ611316A (en) | 2010-12-01 | 2014-12-24 | Univ Australian | Histone inhibition |
| US11203772B2 (en) | 2010-12-23 | 2021-12-21 | The University Of North Carolina At Chapel Hill | Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins |
| WO2012116048A1 (en) | 2011-02-22 | 2012-08-30 | Rensselaer Polytechnic Institute | Single step heparosan n-deacetylation and depolymerization for making bioengineered heparin |
| US8519189B2 (en) | 2011-06-01 | 2013-08-27 | University Of British Columbia | Polymers for reversing heparin-based anticoagulation |
| US10286047B2 (en) | 2013-03-08 | 2019-05-14 | Csl Behring Gmbh | Treatment and prevention of remote ischemia-reperfusion injury |
| EP3011043B1 (en) * | 2013-06-17 | 2022-05-11 | The University of North Carolina At Chapel Hill | Reversible heparin molecules |
| US11993627B2 (en) | 2017-07-03 | 2024-05-28 | The University Of North Carolina At Chapel Hill | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides |
| EP3691653B1 (en) | 2017-11-03 | 2025-03-12 | The University Of North Carolina At Chapel Hill | Sulfated oligosaccharides having anti-inflammatory activity |
| EP3810152A4 (en) | 2018-06-20 | 2022-04-27 | The University of North Carolina at Chapel Hill | CELL PROTECTION METHODS AND COMPOSITIONS |
| JP2023501568A (ja) | 2019-11-13 | 2023-01-18 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 肝虚血再灌流障害におけるヘパラン硫酸（ｈｓ）オリゴ糖の効果 |
| JP7670561B2 (ja) | 2021-06-28 | 2025-04-30 | 日本航空電子工業株式会社 | コネクタ |
-
2018
- 2018-03-12 CN CN201880020095.XA patent/CN110446511B/zh active Active
- 2018-03-12 CN CN202310342719.2A patent/CN116622006B/zh active Active
- 2018-03-12 US US16/492,858 patent/US11903963B2/en active Active
- 2018-03-12 JP JP2019549419A patent/JP7330893B2/ja active Active
- 2018-03-12 WO PCT/US2018/021986 patent/WO2018165656A1/en not_active Ceased
- 2018-03-12 EP EP18764628.6A patent/EP3579897A4/en active Pending
-
2023
- 2023-07-17 US US18/222,910 patent/US20240066048A1/en active Pending
- 2023-08-09 JP JP2023129964A patent/JP7702454B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510119A5 (enExample) | ||
| US5958899A (en) | Polysaccharides having a high iduronic acid content | |
| JP2016523535A5 (enExample) | ||
| JP2023166387A5 (enExample) | ||
| Xu et al. | Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities | |
| Casu et al. | Re-visiting the structure of heparin | |
| PT1556414E (pt) | Misturas de oligossacáridos derivados de heparina, sua preparação e composições farmacêuticas que as contêm | |
| JP2003523460A5 (enExample) | ||
| RU2014129816A (ru) | Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение | |
| PT1226148E (pt) | Novos oligossacáridos, sua preparação e composições farmacêuticas que os contêm | |
| JP2013525306A5 (enExample) | ||
| IL128018A (en) | Artificial polysaccharides containing sulfonate method of preparation and pharmaceutical preparations containing them | |
| Wu et al. | Facile chemoenzymatic synthesis of biotinylated heparosan hexasaccharide | |
| TW550267B (en) | Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them | |
| HU218600B (hu) | Eljárás deszulfatált poliszacharid előállítására, deszulfatált heparin alkalmazása gyógyászati készítmény előállítására | |
| JPS6036492A (ja) | スルフエート置換したオリゴ糖類及びその製造方法 | |
| JP2012526174A (ja) | 新規なアシル化十糖類および抗血栓剤としてのこの使用 | |
| Liu et al. | Synthesis of anticoagulant pentasaccharide fondaparinux via 3, 5-dimethyl-4-(2′-phenylethynylphenyl) phenyl glycosides | |
| CN108912237B (zh) | N-脱硫酸化糖胺聚糖的衍生物以及作为药物的用途 | |
| AU2010283614B2 (en) | FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof | |
| JP5053512B2 (ja) | 非常に大きい硫酸化度を持つｋ５多糖体のエピマー化誘導体 | |
| CN115417937A (zh) | 一种含双抗凝血酶结合序列的肝素十二糖及其制备方法与应用 | |
| US11306157B2 (en) | Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly | |
| Weïwer et al. | Synthesis of uridine 5′-diphosphoiduronic acid: A potential substrate for the chemoenzymatic synthesis of heparin | |
| Cai et al. | Preparation and application of a ‘clickable’acceptor for enzymatic synthesis of heparin oligosaccharides |